Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pickar

Showing results (171-180 of 268) with videos related to

Pageof 27
Sort By:
Lancet (London, England)|November 14, 1981
Behavioural effects after high dose naloxone administration to normal volunteersM R Cohen, R M Cohen, D Pickar, et al.
Schizophrenia Research|May 24, 1997
CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteersM H Rapaport, C G McAllister, D Pickar, et al.
Archives of General Psychiatry|March 1, 1985
Atrophy limited to the third ventricle in chronic schizophrenic patients. Report of a controlled seriesJ Boronow, D Pickar, P T Ninan, et al.
European Journal of Pharmacology|May 7, 1982
Cardiovascular changes in response to selective monoamine oxidase inhibition in the ratR M Cohen, I C Campbell, I Yamaguchi, et al.
Lancet (London, England)|April 26, 1980
Plasma opioid activity in manic-depressive illnessD Pickar, N R Cutler, D Naber, et al.
Archives of General Psychiatry|May 1, 1997
The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance taskR M Cohen, T E Nordahl, W E Semple, et al.
Archives of General Psychiatry|July 1, 1988
Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary resultsO M Wolkowitz, A Breier, A Doran, et al.
Psychiatry Research|October 1, 1987
Morphological brain abnormalities in schizophrenia determined by computed tomography: a problem of measurement?S Raz, N Raz, D R Weinberger, et al.
The American Journal of Psychiatry|December 8, 1998
Cognitive substrates of thought disorder, II: specifying a candidate cognitive mechanismM S Aloia, M L Gourovitch, D Missar, et al.
Pharmacology, Biochemistry, and Behavior|December 1, 1985
Chronic clorgyline and pargyline increase apomorphine-induced stereotypy in the ratI C Campbell, M J Durcan, R M Cohen, et al.
Pageof 27

Showing results (171-180 of 268) with videos related to

Sort By:
Pageof 27
Lancet (London, England)|November 14, 1981
Behavioural effects after high dose naloxone administration to normal volunteersM R Cohen, R M Cohen, D Pickar, et al.
Schizophrenia Research|May 24, 1997
CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteersM H Rapaport, C G McAllister, D Pickar, et al.
Archives of General Psychiatry|March 1, 1985
Atrophy limited to the third ventricle in chronic schizophrenic patients. Report of a controlled seriesJ Boronow, D Pickar, P T Ninan, et al.
European Journal of Pharmacology|May 7, 1982
Cardiovascular changes in response to selective monoamine oxidase inhibition in the ratR M Cohen, I C Campbell, I Yamaguchi, et al.
Lancet (London, England)|April 26, 1980
Plasma opioid activity in manic-depressive illnessD Pickar, N R Cutler, D Naber, et al.
Archives of General Psychiatry|May 1, 1997
The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance taskR M Cohen, T E Nordahl, W E Semple, et al.
Archives of General Psychiatry|July 1, 1988
Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary resultsO M Wolkowitz, A Breier, A Doran, et al.
Psychiatry Research|October 1, 1987
Morphological brain abnormalities in schizophrenia determined by computed tomography: a problem of measurement?S Raz, N Raz, D R Weinberger, et al.
The American Journal of Psychiatry|December 8, 1998
Cognitive substrates of thought disorder, II: specifying a candidate cognitive mechanismM S Aloia, M L Gourovitch, D Missar, et al.
Pharmacology, Biochemistry, and Behavior|December 1, 1985
Chronic clorgyline and pargyline increase apomorphine-induced stereotypy in the ratI C Campbell, M J Durcan, R M Cohen, et al.
Pageof 27